|
ZNF737 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11340003883242E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.80160003266417E-09 |
| Normal-vs-Stage2 |
8.44510000042042E-07 |
| Normal-vs-Stage3 |
7.20159487599403E-11 |
| Normal-vs-Stage4 |
5.11357622912101E-12 |
| Stage1-vs-Stage2 |
3.997400E-01 |
| Stage1-vs-Stage3 |
1.523560E-02 |
| Stage1-vs-Stage4 |
2.603000E-04 |
| Stage2-vs-Stage3 |
5.976200E-03 |
| Stage2-vs-Stage4 |
5.013000E-04 |
| Stage3-vs-Stage4 |
1.661230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.86489975976201E-10 |
| Normal-vs-AfricanAmerican |
1.29669999959781E-07 |
| Normal-vs-Asian |
4.63460048116815E-10 |
| Caucasian-vs-AfricanAmerican |
9.682000E-01 |
| Caucasian-vs-Asian |
4.818800E-01 |
| AfricanAmerican-vs-Asian |
6.916200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.35659999900284E-08 |
| Normal-vs-Female |
6.78100020579109E-10 |
| Male-vs-Female |
3.801400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.1495999665625E-09 |
| Normal-vs-Age(41-60Yrs) |
7.10539960202539E-10 |
| Normal-vs-Age(61-80Yrs) |
1.50559997802446E-09 |
| Normal-vs-Age(81-100Yrs) |
3.844000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.616800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.023200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.325600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.489000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.277200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.597000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.54100000052615E-07 |
| Classical-VS-Follicular |
3.758000E-02 |
| Classical-VS-Other |
8.018000E-01 |
| Classical-VS-Normal |
2.51349996371886E-09 |
| Tall-VS-Follicular |
9.19830001055999E-09 |
| Tall-VS-Other |
4.866000E-02 |
| Tall-VS-Normal |
2.71005440311001E-13 |
| Follicular-VS-Other |
6.424600E-01 |
| Follicular-VS-Normal |
6.56600000037422E-07 |
| Other-VS-Normal |
4.006500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.88000000514543E-08 |
| Normal-vs-N1 |
5.36348743196413E-12 |
| N0-vs-N1 |
6.08349999999813E-05 |
|
|
